U.S. pharmaceutical industry

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the U.S. pharmaceutical industry

This dossier presents graphs and tables about the U.S. pharmaceutical industry. The U.S. pharma industry has a huge influence on the global pharmaceutical market. This document includes some of the most important key figures on U.S. revenues, top companies, top products, medicine use facts, research and development, and an outlook for the coming years.

Table of contents

  • 1. Contribution to global pharma
    • World pharmaceutical market distribution by submarket 2014-2016

    • World pharmaceutical sales 2014-2016 by region

    • Market share of the leading 10 global pharmaceutical markets 2015

    • Top 10 global pharmaceutical markets: growth 2010-2015

    • Top 50 pharmaceutical companies - Rx sales and R&D spending 2015

    • Top 10 countries in pharmaceutical sector M&As 2016

  • 2. Overview
    • U.S. total medicine spending 2002-2015

    • Leading therapy areas for U.S. spending 2015

    • U.S. top 20 prescribed drugs based on sales 2015

    • Top U.S. pharma products by prescriptions 2015

    • Pharmaceutical channel distribution by U.S. spending 2013-2015

    • Pharmaceutical preparation manufacturing gross output 1998-2015

    • U.S. biopharmaceutical export volume 2003-2015

  • 3. Companies
    • 2016 list of top U.S. biotech and pharmaceutical companies based on revenue

    • Pharmaceutical corporations by U.S. revenue 2015

    • Johnson & Johnson's total revenue 2005-2016

    • Pfizer's total revenue 2006-2016

    • Merck & Co - total revenue 2006-2016

    • Ad spending of pharmaceutical companies in the U.S. 2015

    • Highest pharmaceutical company penalties in the U.S. 2012-2015

  • 4. Research and development
    • Research and development expenditure: U.S. pharmaceutical industry 1995-2015

    • U.S. pharma industry R&D spending as a percent of total revenues 1990-2015

    • Pharmaceuticals: biologic medicines in development 2016 by category

    • Pharmaceuticals: cost of drug development in the U.S. since 1975

    • Number of new drugs launched in the U.S. 2003-2015

    • Number of FDA approved orphan designations in the U.S. 2000-2014

    • U.S. sales growth of new brand medicines 2011-2015

    • R&D expenditure per employee in U.S. sectors 2000-2010

  • 5. Generics
    • Market share of unbranded generics by top 20 companies in U.S. 2014-2015

    • Spending change on branded and generic medicines in the U.S. 2009-2015

    • U.S. brand and generic prescription drug revenue 2005-2015

    • Branded vs. generic U.S. drug prescriptions dispensed 2005-2015

    • Savings through generic drug usage in the U.S. 2005-2015

    • Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue

  • 6. Outlook
    • Forecast of CAGR global pharmaceutical industry by region 2015-2018

    • Global spending on medicines by regional share forecast 2020

    • World pharmaceutical sales by region forecast 2020

    • Top branded biologic drugs in the U.S. that will go generic by 2028

    • Leading U.S. pharmaceutical products by revenue 2022

    • Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2020

  • Language: English
  • Released: November 2016
  • Source(s): Statista
More than 7,500
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
With Statista, you get straight to the point: analyzing data, rather than searching for it.

Dr. Antonella Mei-Pochtler about Statista Senior Vice President, Boston Consulting Group

Any more questions?

Get in touch with us quickly and easily. We are happy to help!